Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections

By Quanxin Long, Xiao-jun Tang, Qiuling Shi, Qin Li, H. Deng, Jun Yuan, Jie-Li Hu, W. Xu, Yong Zhang, Fa-jin Lv and 9 more. Nature Medicine, 2020

2,640 citations recorded by the source corpus.

Subfields: Infectious Diseases, Modeling and Simulation

View Paper: https://www.semanticscholar.org/paper/e8bd726b51df54fca5a66f493937a1a31e45d719

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Infectious Diseases

1. Kwok-Yung Yuen
2. D. Veesler
3. A. Walls
4. M. A. Tortorici
5. K. To
6. V. Cheng
7. Kwok-Hung Chan
8. Shuofeng Yuan

In Modeling and Simulation

1. Kwok-Yung Yuen

Citations in the corpus

• COVID-19 re-infection by a phylogenetically distinct SARS-coronavirus-2 strain confirmed by whole genome sequencing (2020, background): “Another study showed that 40% of asymptomatic individuals are seronegative within 8 weeks after the onset of symptoms [7].”
• Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology (2020, positive): “…have documented the development of IgG, IgA, and IgM against S and N within 2 weeks after onset of symptoms in SARS-CoV-2-infected individuals and analyzed the kinetics in the early convalescent phase (Long et al., 2020; Luchsinger et al., 2020; Pre´vost et al., 2020; Robbiani et al., 2020).”
• Amplification-free detection of SARS-CoV-2 with CRISPR-Cas13a and mobile phone microscopy (2020, neutral): “As the long-term immunity induced by natural infection or vaccination may decay in as little as 2–4 months (Ibarrondo et al., 2020; Long et al., 2020), the need for rapid and frequent testing for SARS-CoV-2 will likely remain.”
• Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19 (2020, positive): “However, antibody responses are not detectable in all patients, especially those with less severe forms of COVID-19 (Long et al., 2020; Mallapaty, 2020; Woloshin et al., 2020).”
• Wearable sensor data and self-reported symptoms for COVID-19 detection (2020, background): “Even when individuals have no symptoms, there is evidence that the majority have lung injury (according to computed tomography (CT) scans), and a large number have abnormalities in inflammatory markers, blood cell counts and liver enzymes 18,22–24 .”